PN 30 mg
A polymer composed of linked nucleotide units.
Understanding begins with ingredient identity.
AESTYVE · REVIBE PN
Beyond the
surface.
A new perspective, beginning with ingredients.
Explore Revibe PN from a new angle.
PN 30 mgHA 10 mg2.0 mL
Based on brand-provided specifications
＋
＋
REVIBE / MATERIAL EXPLORER
FORMULA / PER SYRINGE2.0 mLBrand-provided specifications
Loading videoMOVE TO TILT · DRAG TO EXPLORE
01 / INGREDIENT EXPLORER
Clarity, in every layer.
Complex ingredients. Clear information.
HA 10 mg
A polymer with water-binding properties.
Review both composition and ingredient amounts.
Formula 2.0 mL
- PN
- 30 mg
- HA
- 10 mg
- Packaging
- 1 syringe / box
02 / SOURCE TO PRODUCT
Connected by process.
A connected manufacturing foundation, from source to finished product.
Raw materials
Raw material sourcing supported by in-house aquaculture
Extraction & purification
PDRN / PN raw material processing
Product development
Product development and manufacturing
Based on manufacturing partner disclosures · verify against final product specifications
03 / EVIDENCE & UNDERSTANDINGInformation.
Information.
With perspective.
We distinguish ingredient research from product-specific evidence.
Findings from PN studies cannot be directly applied as Revibe clinical outcomes. Consult the current instructions for use and a qualified healthcare professional when considering product suitability and treatment.
PN systematic review · 2025 ↗04 / PRODUCT DOSSIER
A clear basis for product review.
Essential product information for clinic procurement and distribution review.
One formula.
Two ingredients.
A 2.0 mL syringe product formulated with PN and HA. Buyers should review ingredient amounts alongside the supplied product label, instructions for use and market-specific registration scope.
30 + 10 mg
PN / HA · per syringe
Brand-provided specifications- Brand / product name
- Aestyve / Revibe PN
- Ingredient amounts
- PN 30 mg + HA 10 mg
- Volume / packaging
- 2.0 mL × 1 syringe / box
- Professional use
- For professional use by qualified healthcare professionals
- Intended use / scope
- Subject to current local authorization and product IFU
- Storage / expiry
- Refer to the current label and IFU for the supplied product
Amounts shown are brand-provided specifications. Verify them against the latest finished-product specifications before confirming a purchase.
05 / QUALITY & TRACEABILITY
Trust starts with verifiable documentation.
Review the raw material manufacturing foundation separately from finished-product quality documentation.
01 / SOURCE
Trout aquaculture
The starting point of raw material supply
02 / PROCESS
Process operations
Working environment and equipment
03 / PRODUCTION
Production equipment
The foundation for product manufacturing
Based on manufacturing partner disclosuresFrom raw material sourcing
From raw material sourcing
through to product manufacturing
The manufacturing framework spans in-house trout aquaculture and raw material sourcing, PDRN / PN extraction and purification, product development, and OEM/ODM production.
This describes the manufacturing partner's business and process scope. Revibe finished-product amounts, test results and authorized uses must be verified through product-specific documents.
Product identity
Cross-check product name, model, ingredient amounts and packaging across quotations, specifications and labels.
Lot traceability
Verify consistency between the supplied lot, expiry date, packaging and shipment documentation.
Test evidence
Read the test parameters, acceptance criteria, results, test date and applicable product or lot together.
Market suitability
Assess destination-market registration and import requirements for the finished product.
Documents for procurement review
Items to request and verify, not a guarantee of availability or supply.Current product specifications
Check composition, ingredient amounts, fill volume, packaging and document version.
Instructions for use / IFU & label
Review intended use, contraindications, precautions, storage and expiry.
Quality & test documentation
Confirm availability of documents such as a COA, and check the applicable lot and test scope.
Registration & certification documents
Verify the registration holder, covered product, issuing body and validity period.
06 / MARKET & SUPPLY
Procurement aligned with your market.
Clinic procurement and distribution require different information. Include the following details with your inquiry.
Clinic procurement
Review begins with the country of use, clinic details, required quantity and target start date.
- Product specifications and packaging
- Local authorized uses and IFU
- Quotation, shipping terms and estimated schedule
Import & distribution partners
Review begins with the target market, import and distribution qualifications, sales channels and expected order plan.
- Documentation required for registration and import
- Expected volume, commercial and logistics terms
- Labeling, languages and distribution rights to discuss
MOQ / pricing
Request a quote based on quantity, country and commercial terms
Samples / evaluation
Confirm availability and local import requirements
Lead time / shipping
Confirm stock, production, customs and transport conditions
Labeling / customization
Confirm scope, minimum quantity and registration implications
These items are subject to discussion. Pricing, MOQ, lead times, exclusivity and customization are governed by the final quotation and agreement.
07 / PARTNER JOURNEY
From inquiry to an informed decision.
A clear sequence for your procurement review.
- 01 / MARKET
Market & requirements
Share country, business type, product, quantity and target timing.
- 02 / DOCUMENTS
Product & document review
Review specifications, labels, IFU and required registration documents.
- 03 / TERMS
Commercial terms
Discuss unit price, MOQ, payment, shipping, lead time and sample terms.
- 04 / CONFIRMATION
Procurement decision
Confirm available supply and agreed terms in writing.
08 / BUYER FAQ
Questions buyers ask first.
Are PN and PDRN the same ingredient?
Both terms describe DNA-derived materials, but molecular weight distribution, composition and physical properties vary by product. Do not assume identical uses or effects; consult each product's specifications and IFU.
What does PN 30 mg + HA 10 mg refer to?
This page uses the brand-provided amounts per 2.0 mL syringe. Before a final order, compare the latest finished-product specifications with the actual supply label. Ingredient amounts alone cannot establish clinical superiority over another product.
Do published PN studies report Revibe clinical results?
No. PN literature is provided for ingredient understanding. Formulations, study populations and assessment methods vary, so these studies should not be read as Revibe-specific clinical trials or a guarantee of equivalent effects.
Can it be sold or used in our country?
Sale and use depend on local product registration, import requirements and authorized intended use. Verify these against the destination country and importing entity. Publication of this page does not establish local authorization to supply.
How do I confirm MOQ, price and lead time?
Include your target country, quantity, planned start date and delivery destination. Availability and a quotation must be confirmed for your circumstances. Unconfirmed prices or lead times are not listed on this page.
Which documents should I request before procurement?
Start with current specifications, IFU and labeling. Quality, test and registration documents may also be requested according to local requirements. Confirm each document's availability, applicable product or lot, and validity.
How should storage and expiry be managed?
Use the current label and IFU of the actual supplied product. Before ordering, agree on the expiry of incoming stock, transport conditions and packaging checks on receipt.
What if there is a post-treatment reaction or a product quality question?
Contact the treating healthcare professional about treatment-related symptoms. For product quality questions, provide the supplier with the product name, lot, expiry and packaging condition. Do not include patient personal information or medical photographs in a general inquiry.
09 / START A CONVERSATION
Start your next review.
Prepare a product or distribution inquiry with the information you need.
info@aestyve.com ↗Product information for partners
Key product specifications
PN 30 mg + HA 10 mg · 2.0 mL / syringe
Manufacturing & lot review
Manufacturing-document scope is reviewed against the supplied product’s label, lot and expiry. Manufacturing information is provided on a product-specific basis.
Product documentation
Request specifications, labeling / IFU, applicable finished-product CoA and registration documents. Document availability is confirmed for the product and destination market.
Market availability
Tell us your destination country and importing entity. Availability is confirmed after review of product-specific registration and import requirements.
Displayed specifications follow brand-provided information. Verify the current supply label and specifications when ordering.
Quality, reviewed through specific criteria.
We review raw-material and finished-product documentation according to the product’s characteristics and applicable specifications.
Composition & properties
Material identity, composition, concentration, pH and product-specific physical specifications
Finished-product testing
Applicable sterility or microbial, endotoxin and residual-substance test parameters
Lot traceability & packaging
Lot number, expiry, fill volume, package integrity and storage conditions
For PN + HA products, we review ingredient identity, concentration, molecular-weight specifications and formulation-specific test records.
We publish certifications and test values only when valid supporting documents have been verified for the relevant product, model, manufacturing site or lot. We check the issuer, issue date and scope, and distinguish raw-material results from finished-product results.
These are product-specific review criteria, not a statement that every product has completed every test or holds a certification.